These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29691083)

  • 21. [Not Available].
    Aktuelle Urol; 2020 Feb; 51(1):10. PubMed ID: 32018324
    [No Abstract]   [Full Text] [Related]  

  • 22. [Not Available].
    Aktuelle Urol; 2019 Feb; 50(1):12. PubMed ID: 30731495
    [No Abstract]   [Full Text] [Related]  

  • 23. Maculopapular-type drug eruptions caused by apalutamide: case series and a review of the literature.
    Shima K; Nomura T; Yamada Y; Usui S; Kobayashi T; Kabashima K
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e113-e115. PubMed ID: 34510570
    [No Abstract]   [Full Text] [Related]  

  • 24. [A multicentric, randomized, double-blind, placebo-controlled Phase III study of ARN-509 in men with non-metastatic (M0) castration-resistant prostate cancer (SPARTAN): AUO study AP 82/14].
    Rexer H; Hammerer P
    Urologe A; 2016 Mar; 55(3):395-7. PubMed ID: 26820656
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men with Castration-Resistant Prostate Cancer.
    Taneja SS
    J Urol; 2016 Sep; 196(3):742. PubMed ID: 27597066
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.
    Thompson IM; Tangen CM; Paradelo J; Lucia MS; Miller G; Troyer D; Messing E; Forman J; Chin J; Swanson G; Canby-Hagino E; Crawford ED
    JAMA; 2006 Nov; 296(19):2329-35. PubMed ID: 17105795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A method for preparation of amino acid thiohydantoins from free amino acids activated by acetyl chloride for development of protein C-terminal sequencing.
    Mo B; Li J; Liang S
    Anal Biochem; 1997 Jul; 249(2):207-11. PubMed ID: 9212872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time.
    Taneja SS
    J Urol; 2014 Aug; 192(2):421-2. PubMed ID: 25034990
    [No Abstract]   [Full Text] [Related]  

  • 29. Exploring the tetrahydroisoquinoline thiohydantoin scaffold blockade the androgen receptor as potent anti-prostate cancer agents.
    Xu X; Ge R; Li L; Wang J; Lu X; Xue S; Chen X; Li Z; Bian J
    Eur J Med Chem; 2018 Jan; 143():1325-1344. PubMed ID: 29117897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer.
    Yoshino H; Sato H; Shiraishi T; Tachibana K; Emura T; Honma A; Ishikura N; Tsunenari T; Watanabe M; Nishimoto A; Nakamura R; Nakagawa T; Ohta M; Takata N; Furumoto K; Kimura K; Kawata H
    Bioorg Med Chem; 2010 Dec; 18(23):8150-7. PubMed ID: 21050768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience.
    Musunuru HB; Yamamoto T; Klotz L; Ghanem G; Mamedov A; Sethukavalan P; Jethava V; Jain S; Zhang L; Vesprini D; Loblaw A
    J Urol; 2016 Dec; 196(6):1651-1658. PubMed ID: 27569437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Oncologic Outcomes of Salvage Cryoablation for Radio-Recurrent Prostate Cancer.
    Siddiqui KM; Billia M; Al-Zahrani A; Williams A; Goodman C; Arifin A; Violette P; Bauman G; Chin JL
    J Urol; 2016 Oct; 196(4):1105-11. PubMed ID: 27157372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiohydantoins; preparation of 5:5-disubstituted 2: 4-dithiohydantoins from the corresponding ketones.
    CARRINGTON HC
    J Chem Soc; 1947 May; ():681-3. PubMed ID: 20253209
    [No Abstract]   [Full Text] [Related]  

  • 34. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival.
    Cheville JC; Tindall D; Boelter C; Jenkins R; Lohse CM; Pankratz VS; Sebo TJ; Davis B; Blute ML
    Cancer; 2002 Sep; 95(5):1028-36. PubMed ID: 12209687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
    Thüroff S; Chaussy C
    J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result.
    Fiamegos A; Varkarakis J; Kontraros M; Karagiannis A; Chrisofos M; Barbalias D; Deliveliotis C
    Int Braz J Urol; 2016; 42(5):925-931. PubMed ID: 27532110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
    Kawata H; Arai S; Nakagawa T; Ishikura N; Nishimoto A; Yoshino H; Shiraishi T; Tachibana K; Nakamura R; Sato H
    Prostate; 2011 Sep; 71(12):1344-56. PubMed ID: 21308717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival and PSA-markers for mortality and metastasis in nonmetastatic prostate cancer treated with androgen deprivation therapy.
    Nguyen-Nielsen M; Liede A; Maegbaek ML; Borre M; Harving N; Hernandez RK; Sørensen HT; Ehrenstein V
    Cancer Epidemiol; 2015 Aug; 39(4):623-32. PubMed ID: 26100365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long leukocyte telomere length in prostate cancer patients at diagnosis is associated with poor metastasis-free and cancer-specific survival.
    Svenson U; Roos G; Wikström P
    Tumour Biol; 2017 Feb; 39(2):1010428317692236. PubMed ID: 28222672
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.